Press Releases
Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells
Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. These hepatic non-parenchymal...
Press Releases
Cleveland Clinic and Brooks Automation Announce New Biobanking Facility
Cleveland Clinic and Brooks Automation. Inc. willlaunch a 21,000-square-foot biorepository in Cleveland’s Fairfax neighborhood to enhance researchers’ study of human tissue samples and advance personalized...
Press Releases
UCB announces BRIVIACT now approved by FDA to treat partial-onset seizures in pediatric epilepsy patients
UCB announced that the U.S. FDA has approved a supplemental new drug application (sNDA) for the company’s newest anti-epileptic drug BRIVIACT CV oral formulations indicated...
Press Releases
Novartis announces FDA approval of Gilenya as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
Novartis announced that the US FDA has approved Gilenya® (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age...
Press Releases
ChargePoint Technology Launches First-of-its-kind Smart Monitoring Technology at ACHEMA 2018
Powder containment and aseptic transfer valve specialist, ChargePoint Technology, has launched a unique Smart monitoring hub to support efficiency and safety within chemical and pharmaceutical...
Press Releases
CRF Health’s eCOA Solution Selected for Large-Scale Insomnia Study by Innovative European Pharmaceutical Company
CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that its electronic Clinical Outcome Assessment (eCOA) solutions have been selected...
Press Releases
WuXi STA Changzhou Site Passes First U.S. FDA Inspection
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, announces that its active pharmaceutical ingredient (API) R&D and manufacturing facility located in Changzhou, China has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.